Björn Schniedewind

499 total citations
23 papers, 381 citations indexed

About

Björn Schniedewind is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Infectious Diseases. According to data from OpenAlex, Björn Schniedewind has authored 23 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Transplantation, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Infectious Diseases. Recurrent topics in Björn Schniedewind's work include Renal Transplantation Outcomes and Treatments (9 papers), HIV/AIDS drug development and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Björn Schniedewind is often cited by papers focused on Renal Transplantation Outcomes and Treatments (9 papers), HIV/AIDS drug development and treatment (5 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Björn Schniedewind collaborates with scholars based in United States, Germany and Thailand. Björn Schniedewind's co-authors include Uwe Christians, Keith L. Hoffman, Jeffrey L. Galinkin, Jost Klawitter, Touraj Shokati, Alexander A. Vinks, Rachel R. Taylor, Wenzel Schöning, Jelena Klawitter and Karen R. Jonscher and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Journal of Chromatography A.

In The Last Decade

Björn Schniedewind

23 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Björn Schniedewind United States 13 97 96 66 59 56 23 381
Radosław Jaźwiec Poland 12 247 2.5× 93 1.0× 54 0.8× 35 0.6× 35 0.6× 31 553
Karim Aouam Tunisia 14 86 0.9× 106 1.1× 112 1.7× 274 4.6× 40 0.7× 100 728
Caroline Barau France 15 257 2.6× 104 1.1× 58 0.9× 37 0.6× 38 0.7× 46 679
Tilo Wuensch Germany 13 163 1.7× 89 0.9× 34 0.5× 38 0.6× 26 0.5× 18 591
Elodie Gautier‐Veyret France 16 111 1.1× 42 0.4× 63 1.0× 123 2.1× 120 2.1× 39 657
Chadi Abbara France 12 102 1.1× 34 0.4× 44 0.7× 94 1.6× 11 0.2× 58 464
RM Weinshilboum United States 9 102 1.1× 32 0.3× 91 1.4× 14 0.2× 21 0.4× 15 439
Stefania Salardi Italy 14 320 3.3× 43 0.4× 101 1.5× 52 0.9× 374 6.7× 24 1.1k
Isabelle Benz‐de Bretagne France 12 130 1.3× 15 0.2× 43 0.7× 30 0.5× 9 0.2× 32 425
J. A. Duley United Kingdom 11 200 2.1× 17 0.2× 73 1.1× 10 0.2× 20 0.4× 25 436

Countries citing papers authored by Björn Schniedewind

Since Specialization
Citations

This map shows the geographic impact of Björn Schniedewind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Schniedewind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Schniedewind more than expected).

Fields of papers citing papers by Björn Schniedewind

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Schniedewind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Schniedewind. The network helps show where Björn Schniedewind may publish in the future.

Co-authorship network of co-authors of Björn Schniedewind

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Schniedewind. A scholar is included among the top collaborators of Björn Schniedewind based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Schniedewind. Björn Schniedewind is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hove, Johan L.K. Van, Marisa W. Friederich, Daniella H. Hock, et al.. (2024). ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosis. Mitochondrion. 78. 101905–101905. 3 indexed citations
2.
DeWitt, Peter E., Jennifer Wen, Björn Schniedewind, et al.. (2024). Adiponectin and Glucocorticoids Modulate Risk for Preterm Birth: The Healthy Start Study. The Journal of Clinical Endocrinology & Metabolism. 110(2). 523–533. 2 indexed citations
3.
Hadamitzky, Martin, et al.. (2024). The Effects of Fingolimod (FTY720) on Leukocyte Subset Circulation cannot be Behaviourally Conditioned in Rats. Journal of Neuroimmune Pharmacology. 19(1). 18–18. 1 indexed citations
4.
Schniedewind, Björn, et al.. (2024). Minimum effective dose of clemastine in a mouse model of preterm white matter injury. Pediatric Research. 96(4). 933–941. 3 indexed citations
5.
Wilkey, Barbara, Alexander Kaizer, Björn Schniedewind, et al.. (2022). Lidocaine Intraoperative Infusion Pharmacokinetics during Partial Hepatectomy for Living Liver Donation. Anesthesiology. 138(1). 71–81. 3 indexed citations
6.
Ye, Haobin, Mohammad Minhajuddin, Anna Krug, et al.. (2020). The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG. Cancer Discovery. 11(2). 500–519. 19 indexed citations
7.
8.
Fæste, Christiane Kruse, Anders Moen, Björn Schniedewind, et al.. (2016). Development of liquid chromatography-tandem mass spectrometry methods for the quantitation of Anisakis simplex proteins in fish. Journal of Chromatography A. 1432. 58–72. 24 indexed citations
9.
Shokati, Touraj, Björn Schniedewind, Alexander A. Vinks, et al.. (2015). Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS. Journal of Visualized Experiments. e52424–e52424. 27 indexed citations
10.
Hadamitzky, Martin, Timo Wirth, Uwe Christians, et al.. (2015). Memory-updating abrogates extinction of learned immunosuppression. Brain Behavior and Immunity. 52. 40–48. 24 indexed citations
11.
Schniedewind, Björn, et al.. (2015). Long-Term Cross-Validation of Everolimus Therapeutic Drug Monitoring Assays. Therapeutic Drug Monitoring. 37(3). 296–303. 12 indexed citations
12.
Emoto, Chie, Tsuyoshi Fukuda, Tomoyuki Mizuno, et al.. (2014). Age-Dependent Changes in Sirolimus Metabolite Formation in Patients With Neurofibromatosis Type 1. Therapeutic Drug Monitoring. 37(3). 395–399. 11 indexed citations
13.
Chitnis, Shripad, K. OGASAWARA, Björn Schniedewind, et al.. (2013). Concentration of tacrolimus and major metabolites in kidney transplant recipients as a function of diabetes mellitus and cytochrome P450 3A gene polymorphism. Xenobiotica. 43(7). 641–649. 19 indexed citations
14.
Taylor, Rachel R., et al.. (2013). Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 83. 1–9. 40 indexed citations
15.
Aquilante, Christina L., Robert L. Page, Andreas Brieke, et al.. (2013). SLCO1B1 Genotype Influences the Drug-Drug Interaction between Cyclosporine and Pravastatin. The Journal of Heart and Lung Transplantation. 32(4). S292–S293. 1 indexed citations
16.
Schöning, Wenzel, Jelena Klawitter, Nina Brunner, et al.. (2012). Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat. PLoS ONE. 7(10). e48063–e48063. 16 indexed citations
17.
Klepacki, Jacek, Jelena Klawitter, Jamie Bendrick‐Peart, et al.. (2011). A high-throughput U-HPLC–MS/MS assay for the quantification of mycophenolic acid and its major metabolites mycophenolic acid glucuronide and mycophenolic acid acyl-glucuronide in human plasma and urine. Journal of Chromatography B. 883-884. 113–119. 39 indexed citations
18.
Aquilante, Christina L., Jennifer J. Kiser, Peter L. Anderson, et al.. (2011). Influence ofSLCO1B1Polymorphisms on the Drug‐Drug Interaction Between Darunavir/Ritonavir and Pravastatin. The Journal of Clinical Pharmacology. 52(11). 1725–1738. 19 indexed citations
19.
Thomas, James J., Meghan Cromie, Björn Schniedewind, et al.. (2011). A low blood volume LC‐MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children. Journal of Separation Science. 34(24). 3568–3577. 37 indexed citations
20.
Laudi, Sven, Wolfgang Steudel, Karen R. Jonscher, et al.. (2007). Comparison of lung proteome profiles in two rodent models of pulmonary arterial hypertension. PROTEOMICS. 7(14). 2469–2478. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radosław Jaźwiec Breakdown of academic impact, for papers by Karim Aouam Breakdown of academic impact, for papers by Caroline Barau Breakdown of academic impact, for papers by Tilo Wuensch Breakdown of academic impact, for papers by Elodie Gautier‐Veyret Breakdown of academic impact, for papers by Chadi Abbara Breakdown of academic impact, for papers by RM Weinshilboum Breakdown of academic impact, for papers by Stefania Salardi Breakdown of academic impact, for papers by Isabelle Benz‐de Bretagne Breakdown of academic impact, for papers by J. A. Duley
Rankless by CCL
2026